nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ALB—liver cancer	0.197	1	CbGaD
Losartan—UGT2B7—Epirubicin—liver cancer	0.152	0.322	CbGbCtD
Losartan—UGT1A1—Sorafenib—liver cancer	0.115	0.244	CbGbCtD
Losartan—CYP3A5—Sorafenib—liver cancer	0.0351	0.0742	CbGbCtD
Losartan—CYP2C8—Sorafenib—liver cancer	0.0338	0.0714	CbGbCtD
Losartan—CYP2C19—Sorafenib—liver cancer	0.0283	0.0599	CbGbCtD
Losartan—CYP1A2—Sorafenib—liver cancer	0.0261	0.0552	CbGbCtD
Losartan—CYP2C9—Sorafenib—liver cancer	0.0235	0.0498	CbGbCtD
Losartan—ABCB1—Sorafenib—liver cancer	0.0228	0.0483	CbGbCtD
Losartan—ABCB1—Doxorubicin—liver cancer	0.0139	0.0293	CbGbCtD
Losartan—CYP3A4—Sorafenib—liver cancer	0.0137	0.0289	CbGbCtD
Losartan—CYP3A4—Doxorubicin—liver cancer	0.00831	0.0176	CbGbCtD
Losartan—Irbesartan—JUN—liver cancer	0.00266	0.596	CrCbGaD
Losartan—ACE—umbilical vein—liver cancer	0.00253	0.17	CbGeAlD
Losartan—UGT2B17—liver—liver cancer	0.00244	0.164	CbGeAlD
Losartan—UGT1A10—liver—liver cancer	0.00138	0.0926	CbGeAlD
Losartan—Telmisartan—PPARG—liver cancer	0.00129	0.289	CrCbGaD
Losartan—ALB—gall bladder—liver cancer	0.00109	0.0732	CbGeAlD
Losartan—SLC2A9—liver—liver cancer	0.00108	0.0726	CbGeAlD
Losartan—UGT1A3—liver—liver cancer	0.000971	0.0652	CbGeAlD
Losartan—SLCO1B3—liver—liver cancer	0.000682	0.0458	CbGeAlD
Losartan—ACE—embryo—liver cancer	0.00066	0.0444	CbGeAlD
Losartan—UGT2B7—liver—liver cancer	0.000557	0.0375	CbGeAlD
Losartan—Valsartan—ALB—liver cancer	0.000516	0.115	CrCbGaD
Losartan—UGT1A1—liver—liver cancer	0.000474	0.0319	CbGeAlD
Losartan—Anorexia—Sorafenib—liver cancer	0.000449	0.00429	CcSEcCtD
Losartan—Hyperkalaemia—Doxorubicin—liver cancer	0.000443	0.00424	CcSEcCtD
Losartan—Ecchymosis—Epirubicin—liver cancer	0.000441	0.00421	CcSEcCtD
Losartan—Pulmonary oedema—Epirubicin—liver cancer	0.000434	0.00415	CcSEcCtD
Losartan—Skin exfoliation—Doxorubicin—liver cancer	0.000431	0.00412	CcSEcCtD
Losartan—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000429	0.0041	CcSEcCtD
Losartan—Blood urea increased—Doxorubicin—liver cancer	0.000426	0.00407	CcSEcCtD
Losartan—Aplastic anaemia—Doxorubicin—liver cancer	0.000424	0.00405	CcSEcCtD
Losartan—Dyspnoea—Sorafenib—liver cancer	0.00042	0.00401	CcSEcCtD
Losartan—Dyspepsia—Sorafenib—liver cancer	0.000414	0.00396	CcSEcCtD
Losartan—AGTR1—liver—liver cancer	0.000414	0.0278	CbGeAlD
Losartan—Decreased appetite—Sorafenib—liver cancer	0.000409	0.00391	CcSEcCtD
Losartan—Ecchymosis—Doxorubicin—liver cancer	0.000408	0.0039	CcSEcCtD
Losartan—Diabetes mellitus—Epirubicin—liver cancer	0.000407	0.00389	CcSEcCtD
Losartan—Fatigue—Sorafenib—liver cancer	0.000406	0.00388	CcSEcCtD
Losartan—Photosensitivity—Epirubicin—liver cancer	0.000403	0.00385	CcSEcCtD
Losartan—Pain—Sorafenib—liver cancer	0.000403	0.00385	CcSEcCtD
Losartan—Constipation—Sorafenib—liver cancer	0.000403	0.00385	CcSEcCtD
Losartan—Pulmonary oedema—Doxorubicin—liver cancer	0.000402	0.00384	CcSEcCtD
Losartan—Vascular purpura—Epirubicin—liver cancer	0.000396	0.00378	CcSEcCtD
Losartan—SLCO1B1—liver—liver cancer	0.000394	0.0265	CbGeAlD
Losartan—Gastrointestinal pain—Sorafenib—liver cancer	0.000385	0.00368	CcSEcCtD
Losartan—Diabetes mellitus—Doxorubicin—liver cancer	0.000377	0.0036	CcSEcCtD
Losartan—Dermatitis exfoliative—Epirubicin—liver cancer	0.000375	0.00359	CcSEcCtD
Losartan—Urticaria—Sorafenib—liver cancer	0.000374	0.00358	CcSEcCtD
Losartan—Photosensitivity—Doxorubicin—liver cancer	0.000373	0.00357	CcSEcCtD
Losartan—Abdominal pain—Sorafenib—liver cancer	0.000372	0.00356	CcSEcCtD
Losartan—Body temperature increased—Sorafenib—liver cancer	0.000372	0.00356	CcSEcCtD
Losartan—Renal impairment—Epirubicin—liver cancer	0.000372	0.00356	CcSEcCtD
Losartan—Purpura—Epirubicin—liver cancer	0.000367	0.00351	CcSEcCtD
Losartan—Vascular purpura—Doxorubicin—liver cancer	0.000366	0.0035	CcSEcCtD
Losartan—Hypoglycaemia—Epirubicin—liver cancer	0.000363	0.00347	CcSEcCtD
Losartan—Hyponatraemia—Epirubicin—liver cancer	0.000355	0.0034	CcSEcCtD
Losartan—Pain in extremity—Epirubicin—liver cancer	0.000354	0.00338	CcSEcCtD
Losartan—Migraine—Epirubicin—liver cancer	0.000348	0.00333	CcSEcCtD
Losartan—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000347	0.00332	CcSEcCtD
Losartan—Hypersensitivity—Sorafenib—liver cancer	0.000347	0.00332	CcSEcCtD
Losartan—Renal impairment—Doxorubicin—liver cancer	0.000344	0.00329	CcSEcCtD
Losartan—Face oedema—Epirubicin—liver cancer	0.000342	0.00327	CcSEcCtD
Losartan—Purpura—Doxorubicin—liver cancer	0.00034	0.00325	CcSEcCtD
Losartan—Asthenia—Sorafenib—liver cancer	0.000338	0.00323	CcSEcCtD
Losartan—Hypoglycaemia—Doxorubicin—liver cancer	0.000336	0.00321	CcSEcCtD
Losartan—Pruritus—Sorafenib—liver cancer	0.000333	0.00318	CcSEcCtD
Losartan—Ataxia—Epirubicin—liver cancer	0.000333	0.00318	CcSEcCtD
Losartan—Blood creatinine increased—Epirubicin—liver cancer	0.000332	0.00317	CcSEcCtD
Losartan—Hyponatraemia—Doxorubicin—liver cancer	0.000329	0.00314	CcSEcCtD
Losartan—Pain in extremity—Doxorubicin—liver cancer	0.000328	0.00313	CcSEcCtD
Losartan—Dry skin—Epirubicin—liver cancer	0.000324	0.0031	CcSEcCtD
Losartan—Orthostatic hypotension—Epirubicin—liver cancer	0.000323	0.00309	CcSEcCtD
Losartan—Migraine—Doxorubicin—liver cancer	0.000322	0.00308	CcSEcCtD
Losartan—Diarrhoea—Sorafenib—liver cancer	0.000322	0.00308	CcSEcCtD
Losartan—Breast disorder—Epirubicin—liver cancer	0.00032	0.00306	CcSEcCtD
Losartan—ALB—liver—liver cancer	0.000319	0.0215	CbGeAlD
Losartan—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000319	0.00305	CcSEcCtD
Losartan—Face oedema—Doxorubicin—liver cancer	0.000316	0.00302	CcSEcCtD
Losartan—Gastritis—Epirubicin—liver cancer	0.000313	0.00299	CcSEcCtD
Losartan—Muscular weakness—Epirubicin—liver cancer	0.000312	0.00298	CcSEcCtD
Losartan—Dizziness—Sorafenib—liver cancer	0.000311	0.00298	CcSEcCtD
Losartan—Ataxia—Doxorubicin—liver cancer	0.000308	0.00294	CcSEcCtD
Losartan—Blood creatinine increased—Doxorubicin—liver cancer	0.000307	0.00293	CcSEcCtD
Losartan—Influenza—Epirubicin—liver cancer	0.000306	0.00292	CcSEcCtD
Losartan—ACE—liver—liver cancer	0.000305	0.0205	CbGeAlD
Losartan—Eosinophilia—Epirubicin—liver cancer	0.000303	0.0029	CcSEcCtD
Losartan—Dry skin—Doxorubicin—liver cancer	0.0003	0.00287	CcSEcCtD
Losartan—Pancreatitis—Epirubicin—liver cancer	0.0003	0.00287	CcSEcCtD
Losartan—Vomiting—Sorafenib—liver cancer	0.000299	0.00286	CcSEcCtD
Losartan—Orthostatic hypotension—Doxorubicin—liver cancer	0.000299	0.00286	CcSEcCtD
Losartan—Angina pectoris—Epirubicin—liver cancer	0.000298	0.00285	CcSEcCtD
Losartan—Rash—Sorafenib—liver cancer	0.000297	0.00284	CcSEcCtD
Losartan—Dermatitis—Sorafenib—liver cancer	0.000297	0.00283	CcSEcCtD
Losartan—Breast disorder—Doxorubicin—liver cancer	0.000296	0.00283	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000295	0.00282	CcSEcCtD
Losartan—Headache—Sorafenib—liver cancer	0.000295	0.00282	CcSEcCtD
Losartan—Bronchitis—Epirubicin—liver cancer	0.000294	0.00281	CcSEcCtD
Losartan—Gastritis—Doxorubicin—liver cancer	0.00029	0.00277	CcSEcCtD
Losartan—Muscular weakness—Doxorubicin—liver cancer	0.000289	0.00276	CcSEcCtD
Losartan—Upper respiratory tract infection—Epirubicin—liver cancer	0.000284	0.00272	CcSEcCtD
Losartan—Influenza—Doxorubicin—liver cancer	0.000283	0.00271	CcSEcCtD
Losartan—Pollakiuria—Epirubicin—liver cancer	0.000283	0.0027	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—liver cancer	0.00028	0.00268	CcSEcCtD
Losartan—Nausea—Sorafenib—liver cancer	0.00028	0.00267	CcSEcCtD
Losartan—Photosensitivity reaction—Epirubicin—liver cancer	0.000279	0.00267	CcSEcCtD
Losartan—Weight increased—Epirubicin—liver cancer	0.000278	0.00266	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—liver cancer	0.000278	0.00265	CcSEcCtD
Losartan—Hyperglycaemia—Epirubicin—liver cancer	0.000276	0.00264	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—liver cancer	0.000276	0.00264	CcSEcCtD
Losartan—Pneumonia—Epirubicin—liver cancer	0.000274	0.00262	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—liver cancer	0.000272	0.0026	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00027	0.00259	CcSEcCtD
Losartan—Renal failure—Epirubicin—liver cancer	0.000268	0.00256	CcSEcCtD
Losartan—Neuropathy peripheral—Epirubicin—liver cancer	0.000267	0.00256	CcSEcCtD
Losartan—Jaundice—Epirubicin—liver cancer	0.000266	0.00254	CcSEcCtD
Losartan—Conjunctivitis—Epirubicin—liver cancer	0.000265	0.00253	CcSEcCtD
Losartan—Urinary tract infection—Epirubicin—liver cancer	0.000265	0.00253	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000263	0.00252	CcSEcCtD
Losartan—Sweating—Epirubicin—liver cancer	0.000262	0.0025	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—liver cancer	0.000262	0.0025	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—liver cancer	0.000258	0.00247	CcSEcCtD
Losartan—Weight increased—Doxorubicin—liver cancer	0.000258	0.00246	CcSEcCtD
Losartan—Epistaxis—Epirubicin—liver cancer	0.000257	0.00246	CcSEcCtD
Losartan—CYP2C19—liver—liver cancer	0.000257	0.0173	CbGeAlD
Losartan—Sinusitis—Epirubicin—liver cancer	0.000256	0.00245	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—liver cancer	0.000255	0.00244	CcSEcCtD
Losartan—Agranulocytosis—Epirubicin—liver cancer	0.000255	0.00243	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—liver cancer	0.000254	0.00243	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00025	0.00239	CcSEcCtD
Losartan—Renal failure—Doxorubicin—liver cancer	0.000248	0.00237	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—liver cancer	0.000247	0.00237	CcSEcCtD
Losartan—Jaundice—Doxorubicin—liver cancer	0.000246	0.00235	CcSEcCtD
Losartan—Rhinitis—Epirubicin—liver cancer	0.000246	0.00235	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—liver cancer	0.000245	0.00235	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—liver cancer	0.000245	0.00235	CcSEcCtD
Losartan—Hepatitis—Epirubicin—liver cancer	0.000245	0.00234	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—liver cancer	0.000244	0.00233	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—liver cancer	0.000243	0.00232	CcSEcCtD
Losartan—Sweating—Doxorubicin—liver cancer	0.000242	0.00231	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—liver cancer	0.000238	0.00228	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—liver cancer	0.000237	0.00226	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—liver cancer	0.000236	0.00225	CcSEcCtD
Losartan—ABCB1—embryo—liver cancer	0.000232	0.0156	CbGeAlD
Losartan—Erythema multiforme—Epirubicin—liver cancer	0.000232	0.00221	CcSEcCtD
Losartan—Tinnitus—Epirubicin—liver cancer	0.000228	0.00218	CcSEcCtD
Losartan—Flushing—Epirubicin—liver cancer	0.000227	0.00217	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—liver cancer	0.000227	0.00217	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—liver cancer	0.000227	0.00217	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—liver cancer	0.000225	0.00216	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—liver cancer	0.000225	0.00215	CcSEcCtD
Losartan—CYP2C8—liver—liver cancer	0.000224	0.0151	CbGeAlD
Losartan—Angiopathy—Epirubicin—liver cancer	0.000222	0.00212	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—liver cancer	0.000219	0.00209	CcSEcCtD
Losartan—Alopecia—Epirubicin—liver cancer	0.000216	0.00207	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—liver cancer	0.000214	0.00205	CcSEcCtD
Losartan—Erythema—Epirubicin—liver cancer	0.000213	0.00204	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—liver cancer	0.000211	0.00202	CcSEcCtD
Losartan—Flushing—Doxorubicin—liver cancer	0.00021	0.00201	CcSEcCtD
Losartan—Flatulence—Epirubicin—liver cancer	0.00021	0.00201	CcSEcCtD
Losartan—CYP1A2—liver—liver cancer	0.00021	0.0141	CbGeAlD
Losartan—Tension—Epirubicin—liver cancer	0.000209	0.002	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—liver cancer	0.000209	0.002	CcSEcCtD
Losartan—Nervousness—Epirubicin—liver cancer	0.000207	0.00198	CcSEcCtD
Losartan—Back pain—Epirubicin—liver cancer	0.000206	0.00197	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—liver cancer	0.000206	0.00197	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—liver cancer	0.000205	0.00196	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—liver cancer	0.000202	0.00194	CcSEcCtD
Losartan—CYP3A5—liver—liver cancer	0.000202	0.0136	CbGeAlD
Losartan—Vision blurred—Epirubicin—liver cancer	0.000201	0.00192	CcSEcCtD
Losartan—Alopecia—Doxorubicin—liver cancer	0.0002	0.00191	CcSEcCtD
Losartan—CYP2C9—liver—liver cancer	0.000199	0.0134	CbGeAlD
Losartan—Ill-defined disorder—Epirubicin—liver cancer	0.000198	0.00189	CcSEcCtD
Losartan—Erythema—Doxorubicin—liver cancer	0.000197	0.00189	CcSEcCtD
Losartan—Anaemia—Epirubicin—liver cancer	0.000197	0.00188	CcSEcCtD
Losartan—Agitation—Epirubicin—liver cancer	0.000196	0.00187	CcSEcCtD
Losartan—Flatulence—Doxorubicin—liver cancer	0.000194	0.00186	CcSEcCtD
Losartan—Tension—Doxorubicin—liver cancer	0.000194	0.00185	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—liver cancer	0.000193	0.00185	CcSEcCtD
Losartan—Malaise—Epirubicin—liver cancer	0.000192	0.00184	CcSEcCtD
Losartan—Nervousness—Doxorubicin—liver cancer	0.000192	0.00183	CcSEcCtD
Losartan—Vertigo—Epirubicin—liver cancer	0.000192	0.00183	CcSEcCtD
Losartan—Syncope—Epirubicin—liver cancer	0.000191	0.00183	CcSEcCtD
Losartan—Leukopenia—Epirubicin—liver cancer	0.000191	0.00182	CcSEcCtD
Losartan—Back pain—Doxorubicin—liver cancer	0.000191	0.00182	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—liver cancer	0.00019	0.00181	CcSEcCtD
Losartan—Palpitations—Epirubicin—liver cancer	0.000188	0.0018	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—liver cancer	0.000187	0.00179	CcSEcCtD
Losartan—Cough—Epirubicin—liver cancer	0.000186	0.00178	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—liver cancer	0.000186	0.00178	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—liver cancer	0.000183	0.00175	CcSEcCtD
Losartan—Anaemia—Doxorubicin—liver cancer	0.000182	0.00174	CcSEcCtD
Losartan—Chest pain—Epirubicin—liver cancer	0.000182	0.00173	CcSEcCtD
Losartan—Myalgia—Epirubicin—liver cancer	0.000182	0.00173	CcSEcCtD
Losartan—Arthralgia—Epirubicin—liver cancer	0.000182	0.00173	CcSEcCtD
Losartan—Agitation—Doxorubicin—liver cancer	0.000181	0.00173	CcSEcCtD
Losartan—Anxiety—Epirubicin—liver cancer	0.000181	0.00173	CcSEcCtD
Losartan—Discomfort—Epirubicin—liver cancer	0.000179	0.00171	CcSEcCtD
Losartan—Malaise—Doxorubicin—liver cancer	0.000178	0.0017	CcSEcCtD
Losartan—Dry mouth—Epirubicin—liver cancer	0.000178	0.0017	CcSEcCtD
Losartan—Vertigo—Doxorubicin—liver cancer	0.000177	0.00169	CcSEcCtD
Losartan—Syncope—Doxorubicin—liver cancer	0.000177	0.00169	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—liver cancer	0.000177	0.00169	CcSEcCtD
Losartan—Confusional state—Epirubicin—liver cancer	0.000175	0.00168	CcSEcCtD
Losartan—Palpitations—Doxorubicin—liver cancer	0.000174	0.00167	CcSEcCtD
Losartan—Oedema—Epirubicin—liver cancer	0.000174	0.00166	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—liver cancer	0.000174	0.00166	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—liver cancer	0.000173	0.00166	CcSEcCtD
Losartan—Infection—Epirubicin—liver cancer	0.000173	0.00165	CcSEcCtD
Losartan—Cough—Doxorubicin—liver cancer	0.000172	0.00165	CcSEcCtD
Losartan—Shock—Epirubicin—liver cancer	0.000171	0.00164	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—liver cancer	0.000171	0.00163	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—liver cancer	0.00017	0.00163	CcSEcCtD
Losartan—Tachycardia—Epirubicin—liver cancer	0.00017	0.00162	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—liver cancer	0.000168	0.00161	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—liver cancer	0.000168	0.00161	CcSEcCtD
Losartan—Chest pain—Doxorubicin—liver cancer	0.000168	0.00161	CcSEcCtD
Losartan—Myalgia—Doxorubicin—liver cancer	0.000168	0.00161	CcSEcCtD
Losartan—Anxiety—Doxorubicin—liver cancer	0.000167	0.0016	CcSEcCtD
Losartan—Discomfort—Doxorubicin—liver cancer	0.000166	0.00159	CcSEcCtD
Losartan—Anorexia—Epirubicin—liver cancer	0.000166	0.00159	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—liver cancer	0.000164	0.00157	CcSEcCtD
Losartan—Hypotension—Epirubicin—liver cancer	0.000163	0.00155	CcSEcCtD
Losartan—Confusional state—Doxorubicin—liver cancer	0.000162	0.00155	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—liver cancer	0.000161	0.00154	CcSEcCtD
Losartan—Oedema—Doxorubicin—liver cancer	0.000161	0.00154	CcSEcCtD
Losartan—Infection—Doxorubicin—liver cancer	0.00016	0.00153	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000159	0.00152	CcSEcCtD
Losartan—Shock—Doxorubicin—liver cancer	0.000158	0.00151	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—liver cancer	0.000158	0.00151	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—liver cancer	0.000158	0.00151	CcSEcCtD
Losartan—Insomnia—Epirubicin—liver cancer	0.000157	0.0015	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—liver cancer	0.000157	0.0015	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—liver cancer	0.000156	0.00149	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—liver cancer	0.000156	0.00149	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—liver cancer	0.000155	0.00148	CcSEcCtD
Losartan—Somnolence—Epirubicin—liver cancer	0.000155	0.00148	CcSEcCtD
Losartan—Anorexia—Doxorubicin—liver cancer	0.000153	0.00147	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—liver cancer	0.000153	0.00146	CcSEcCtD
Losartan—CYP3A4—liver—liver cancer	0.000152	0.0102	CbGeAlD
Losartan—Decreased appetite—Epirubicin—liver cancer	0.000151	0.00145	CcSEcCtD
Losartan—Hypotension—Doxorubicin—liver cancer	0.00015	0.00144	CcSEcCtD
Losartan—Fatigue—Epirubicin—liver cancer	0.00015	0.00143	CcSEcCtD
Losartan—Constipation—Epirubicin—liver cancer	0.000149	0.00142	CcSEcCtD
Losartan—Pain—Epirubicin—liver cancer	0.000149	0.00142	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000147	0.0014	CcSEcCtD
Losartan—Insomnia—Doxorubicin—liver cancer	0.000146	0.00139	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—liver cancer	0.000145	0.00138	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—liver cancer	0.000144	0.00137	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—liver cancer	0.000143	0.00137	CcSEcCtD
Losartan—Somnolence—Doxorubicin—liver cancer	0.000143	0.00137	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—liver cancer	0.000142	0.00136	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—liver cancer	0.000142	0.00135	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—liver cancer	0.00014	0.00134	CcSEcCtD
Losartan—Fatigue—Doxorubicin—liver cancer	0.000139	0.00133	CcSEcCtD
Losartan—Urticaria—Epirubicin—liver cancer	0.000138	0.00132	CcSEcCtD
Losartan—Pain—Doxorubicin—liver cancer	0.000138	0.00132	CcSEcCtD
Losartan—Constipation—Doxorubicin—liver cancer	0.000138	0.00132	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—liver cancer	0.000138	0.00131	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—liver cancer	0.000138	0.00131	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—liver cancer	0.000133	0.00127	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—liver cancer	0.000132	0.00126	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—liver cancer	0.000128	0.00123	CcSEcCtD
Losartan—Urticaria—Doxorubicin—liver cancer	0.000128	0.00122	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—liver cancer	0.000127	0.00122	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—liver cancer	0.000127	0.00122	CcSEcCtD
Losartan—Asthenia—Epirubicin—liver cancer	0.000125	0.00119	CcSEcCtD
Losartan—Pruritus—Epirubicin—liver cancer	0.000123	0.00118	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—liver cancer	0.000119	0.00114	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—liver cancer	0.000119	0.00113	CcSEcCtD
Losartan—Asthenia—Doxorubicin—liver cancer	0.000116	0.0011	CcSEcCtD
Losartan—Dizziness—Epirubicin—liver cancer	0.000115	0.0011	CcSEcCtD
Losartan—Pruritus—Doxorubicin—liver cancer	0.000114	0.00109	CcSEcCtD
Losartan—Vomiting—Epirubicin—liver cancer	0.000111	0.00106	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—liver cancer	0.00011	0.00105	CcSEcCtD
Losartan—Rash—Epirubicin—liver cancer	0.00011	0.00105	CcSEcCtD
Losartan—Dermatitis—Epirubicin—liver cancer	0.00011	0.00105	CcSEcCtD
Losartan—Headache—Epirubicin—liver cancer	0.000109	0.00104	CcSEcCtD
Losartan—ABCB1—liver—liver cancer	0.000108	0.00723	CbGeAlD
Losartan—Dizziness—Doxorubicin—liver cancer	0.000106	0.00102	CcSEcCtD
Losartan—Nausea—Epirubicin—liver cancer	0.000103	0.000988	CcSEcCtD
Losartan—Vomiting—Doxorubicin—liver cancer	0.000102	0.000978	CcSEcCtD
Losartan—Rash—Doxorubicin—liver cancer	0.000102	0.00097	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—liver cancer	0.000101	0.000969	CcSEcCtD
Losartan—Headache—Doxorubicin—liver cancer	0.000101	0.000964	CcSEcCtD
Losartan—Nausea—Doxorubicin—liver cancer	9.56e-05	0.000914	CcSEcCtD
Losartan—CYP1A2—Metabolism—GSTA1—liver cancer	8.48e-06	4.12e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CB—liver cancer	8.41e-06	4.09e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MTOR—liver cancer	8.41e-06	4.09e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CG—liver cancer	8.39e-06	4.08e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HPGDS—liver cancer	8.39e-06	4.08e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NAT2—liver cancer	8.38e-06	4.08e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GOT2—liver cancer	8.35e-06	4.06e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GOT1—liver cancer	8.33e-06	4.05e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GGT1—liver cancer	8.33e-06	4.05e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GOT2—liver cancer	8.31e-06	4.04e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CB—liver cancer	8.31e-06	4.04e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARG—liver cancer	8.1e-06	3.94e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.08e-06	3.93e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.07e-06	3.92e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.06e-06	3.92e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALDOB—liver cancer	8.04e-06	3.91e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—liver cancer	8.03e-06	3.9e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GLUL—liver cancer	8.03e-06	3.9e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CPT1B—liver cancer	8.03e-06	3.9e-05	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	8.02e-06	3.9e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CB—liver cancer	7.91e-06	3.85e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	7.9e-06	3.84e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1B—liver cancer	7.89e-06	3.84e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP2E1—liver cancer	7.85e-06	3.82e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HPGDS—liver cancer	7.84e-06	3.81e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP2E1—liver cancer	7.81e-06	3.8e-05	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—liver cancer	7.8e-06	3.8e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.8e-06	3.79e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.79e-06	3.79e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NR1H4—liver cancer	7.74e-06	3.76e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CASP3—liver cancer	7.73e-06	3.76e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2—liver cancer	7.72e-06	3.75e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CG—liver cancer	7.69e-06	3.74e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.69e-06	3.74e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—liver cancer	7.68e-06	3.74e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CRABP1—liver cancer	7.67e-06	3.73e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PSMA4—liver cancer	7.66e-06	3.73e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PSMD10—liver cancer	7.66e-06	3.73e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2—liver cancer	7.63e-06	3.71e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTA3—liver cancer	7.61e-06	3.7e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.6e-06	3.7e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.56e-06	3.68e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—liver cancer	7.53e-06	3.66e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—JUN—liver cancer	7.51e-06	3.65e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PSMA4—liver cancer	7.48e-06	3.64e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PSMD10—liver cancer	7.48e-06	3.64e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTP1—liver cancer	7.48e-06	3.64e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GOT2—liver cancer	7.46e-06	3.63e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—liver cancer	7.45e-06	3.62e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—liver cancer	7.42e-06	3.61e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CD—liver cancer	7.38e-06	3.59e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—HMOX1—liver cancer	7.38e-06	3.59e-05	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	7.36e-06	3.58e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYCS—liver cancer	7.35e-06	3.57e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYCS—liver cancer	7.31e-06	3.55e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—liver cancer	7.31e-06	3.55e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—liver cancer	7.28e-06	3.54e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1A—liver cancer	7.28e-06	3.54e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GOT2—liver cancer	7.28e-06	3.54e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GOT1—liver cancer	7.21e-06	3.51e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GGT1—liver cancer	7.21e-06	3.51e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GOT1—liver cancer	7.17e-06	3.49e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GGT1—liver cancer	7.17e-06	3.49e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	7.13e-06	3.47e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK8—liver cancer	7.11e-06	3.46e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.1e-06	3.45e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—liver cancer	7.09e-06	3.45e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP2E1—liver cancer	7.01e-06	3.41e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.01e-06	3.41e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PSMA4—liver cancer	6.99e-06	3.4e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PSMD10—liver cancer	6.99e-06	3.4e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTA4—liver cancer	6.96e-06	3.38e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.9e-06	3.36e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTM1—liver cancer	6.87e-06	3.34e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP2E1—liver cancer	6.84e-06	3.33e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GOT2—liver cancer	6.8e-06	3.31e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.79e-06	3.3e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTA2—liver cancer	6.78e-06	3.3e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CD—liver cancer	6.76e-06	3.29e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HPGDS—liver cancer	6.7e-06	3.26e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—liver cancer	6.67e-06	3.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.66e-06	3.24e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—liver cancer	6.56e-06	3.19e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYCS—liver cancer	6.56e-06	3.19e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTA1—liver cancer	6.54e-06	3.18e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP1A1—liver cancer	6.51e-06	3.17e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—liver cancer	6.5e-06	3.16e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—liver cancer	6.48e-06	3.15e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTP1—liver cancer	6.48e-06	3.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NAT2—liver cancer	6.47e-06	3.15e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	6.45e-06	3.14e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTP1—liver cancer	6.44e-06	3.13e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GGT1—liver cancer	6.44e-06	3.13e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GOT1—liver cancer	6.44e-06	3.13e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CB—liver cancer	6.43e-06	3.13e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYCS—liver cancer	6.4e-06	3.11e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP2E1—liver cancer	6.39e-06	3.11e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HMOX1—liver cancer	6.39e-06	3.11e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—HMOX1—liver cancer	6.35e-06	3.09e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GGT1—liver cancer	6.28e-06	3.06e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GOT1—liver cancer	6.28e-06	3.06e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALDOB—liver cancer	6.2e-06	3.02e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.19e-06	3.01e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTHFR—liver cancer	6.07e-06	2.95e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.07e-06	2.95e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—liver cancer	6.04e-06	2.94e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—liver cancer	6.02e-06	2.93e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.99e-06	2.91e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYCS—liver cancer	5.98e-06	2.91e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PSMD10—liver cancer	5.97e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PSMA4—liver cancer	5.97e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARA—liver cancer	5.96e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—liver cancer	5.95e-06	2.89e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—liver cancer	5.95e-06	2.89e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—liver cancer	5.92e-06	2.88e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CRABP1—liver cancer	5.92e-06	2.88e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CB—liver cancer	5.89e-06	2.87e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GGT1—liver cancer	5.87e-06	2.85e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GOT1—liver cancer	5.87e-06	2.85e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GOT2—liver cancer	5.81e-06	2.83e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTP1—liver cancer	5.78e-06	2.81e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HMOX1—liver cancer	5.7e-06	2.77e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—liver cancer	5.67e-06	2.76e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTP1—liver cancer	5.64e-06	2.74e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1A1—liver cancer	5.64e-06	2.74e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1A1—liver cancer	5.61e-06	2.73e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—liver cancer	5.58e-06	2.71e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HMOX1—liver cancer	5.57e-06	2.71e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—liver cancer	5.51e-06	2.68e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2E1—liver cancer	5.46e-06	2.66e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—liver cancer	5.35e-06	2.6e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—liver cancer	5.31e-06	2.58e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.29e-06	2.57e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTP1—liver cancer	5.27e-06	2.56e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTHFR—liver cancer	5.26e-06	2.56e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—MTHFR—liver cancer	5.23e-06	2.54e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HMOX1—liver cancer	5.2e-06	2.53e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—liver cancer	5.19e-06	2.52e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HPGDS—liver cancer	5.17e-06	2.52e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARA—liver cancer	5.16e-06	2.51e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARA—liver cancer	5.13e-06	2.5e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—liver cancer	5.12e-06	2.49e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYCS—liver cancer	5.11e-06	2.49e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—liver cancer	5.1e-06	2.48e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—liver cancer	5.06e-06	2.46e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1A1—liver cancer	5.04e-06	2.45e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GGT1—liver cancer	5.02e-06	2.44e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GOT1—liver cancer	5.02e-06	2.44e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—liver cancer	4.96e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—liver cancer	4.92e-06	2.4e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1A1—liver cancer	4.92e-06	2.39e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—liver cancer	4.9e-06	2.38e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—liver cancer	4.84e-06	2.36e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—liver cancer	4.82e-06	2.35e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—liver cancer	4.74e-06	2.31e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTHFR—liver cancer	4.7e-06	2.28e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—liver cancer	4.68e-06	2.28e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.64e-06	2.25e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—liver cancer	4.64e-06	2.25e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.61e-06	2.24e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PSMA4—liver cancer	4.61e-06	2.24e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PSMD10—liver cancer	4.61e-06	2.24e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARA—liver cancer	4.61e-06	2.24e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1A1—liver cancer	4.59e-06	2.23e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTHFR—liver cancer	4.58e-06	2.23e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—liver cancer	4.54e-06	2.21e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTP1—liver cancer	4.5e-06	2.19e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARA—liver cancer	4.5e-06	2.19e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CD—liver cancer	4.49e-06	2.18e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GOT2—liver cancer	4.48e-06	2.18e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HMOX1—liver cancer	4.44e-06	2.16e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—liver cancer	4.43e-06	2.15e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—liver cancer	4.42e-06	2.15e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—liver cancer	4.39e-06	2.14e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—liver cancer	4.37e-06	2.12e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTHFR—liver cancer	4.28e-06	2.08e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—liver cancer	4.27e-06	2.07e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—liver cancer	4.24e-06	2.06e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2E1—liver cancer	4.22e-06	2.05e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARA—liver cancer	4.2e-06	2.04e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—liver cancer	4.19e-06	2.04e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—liver cancer	4.14e-06	2.01e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.14e-06	2.01e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—liver cancer	4.14e-06	2.01e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—liver cancer	3.94e-06	1.92e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYCS—liver cancer	3.94e-06	1.92e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—liver cancer	3.94e-06	1.92e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1A1—liver cancer	3.92e-06	1.91e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—liver cancer	3.92e-06	1.91e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CB—liver cancer	3.91e-06	1.9e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CD—liver cancer	3.89e-06	1.89e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GOT1—liver cancer	3.87e-06	1.88e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GGT1—liver cancer	3.87e-06	1.88e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CD—liver cancer	3.86e-06	1.88e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—liver cancer	3.85e-06	1.87e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—liver cancer	3.84e-06	1.87e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—liver cancer	3.81e-06	1.85e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.77e-06	1.83e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—liver cancer	3.72e-06	1.81e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTHFR—liver cancer	3.66e-06	1.78e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—liver cancer	3.6e-06	1.75e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—liver cancer	3.59e-06	1.75e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARA—liver cancer	3.59e-06	1.75e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTP1—liver cancer	3.48e-06	1.69e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—liver cancer	3.47e-06	1.69e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CD—liver cancer	3.47e-06	1.69e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HMOX1—liver cancer	3.43e-06	1.67e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—liver cancer	3.42e-06	1.67e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CB—liver cancer	3.39e-06	1.65e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CD—liver cancer	3.38e-06	1.65e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CB—liver cancer	3.37e-06	1.64e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—liver cancer	3.34e-06	1.63e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.22e-06	1.57e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—liver cancer	3.2e-06	1.56e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—liver cancer	3.19e-06	1.55e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CD—liver cancer	3.16e-06	1.54e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—liver cancer	3.12e-06	1.52e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—liver cancer	3.07e-06	1.5e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1A1—liver cancer	3.03e-06	1.47e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CB—liver cancer	3.02e-06	1.47e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—liver cancer	2.97e-06	1.44e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CB—liver cancer	2.95e-06	1.43e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—liver cancer	2.93e-06	1.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTHFR—liver cancer	2.82e-06	1.37e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARA—liver cancer	2.77e-06	1.35e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CB—liver cancer	2.76e-06	1.34e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CD—liver cancer	2.7e-06	1.31e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—liver cancer	2.67e-06	1.3e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—liver cancer	2.38e-06	1.16e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—liver cancer	2.37e-06	1.15e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CB—liver cancer	2.36e-06	1.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—liver cancer	2.29e-06	1.11e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CD—liver cancer	2.09e-06	1.01e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—liver cancer	2.06e-06	1e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—liver cancer	2.06e-06	1e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—liver cancer	2.05e-06	9.98e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—liver cancer	1.95e-06	9.47e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—liver cancer	1.84e-06	8.96e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CB—liver cancer	1.82e-06	8.84e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—liver cancer	1.8e-06	8.75e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—liver cancer	1.69e-06	8.2e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—liver cancer	1.68e-06	8.17e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—liver cancer	1.68e-06	8.16e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—liver cancer	1.51e-06	7.32e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—liver cancer	1.47e-06	7.15e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—liver cancer	1.44e-06	6.98e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—liver cancer	1.37e-06	6.68e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—liver cancer	1.17e-06	5.7e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—liver cancer	1.11e-06	5.39e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—liver cancer	9.05e-07	4.4e-06	CbGpPWpGaD
